Bacterial Vaginosis (BV) - Competitive Landscape

• More than 248 million total prevalent cases of BV are anticipated in 2023 in the 16 countries covered in the epidemiology forecast for BV.
• Marketed drugs for BV are widely genericized and the majority of drugs indicated to treat BV are antibiotics.
• Out of 29 drugs in the pipeline for BV, only two are in the Phase III stage of development.
• Both commercial and academic sponsors lead the clinical trials space for BV over the past 10 years. TenNor Therapeutics has conducted the highest number of trials (six trials) among commercial sponsors.
• In deals involving companies developing BV assets, acquisitions were the most common deal type across Asia-Pacific, Europe, and North America.

Scope

• Disease Landscape
• Disease Overview
• Epidemiology Overview
• Treatment Overview
• Marketed Products Assessment
• Breakdown by Mechanism of Action, Route of Administration
• Product Profiles with Sales Forecast
• Pricing and Reimbursement Assessment
• Annual Therapy Cost
• Time to Pricing and Time to Reimbursement
• Pipeline Assessment
• Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
• Product Profiles with Sales Forecast
• Late-to-mid-stage Pipeline Drugs
• Phase Transition Success Rate and Likelihood of Approval
• Clinical Trials Assessment
• Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
• Enrolment Analytics, Site Analytics, Feasibility Analysis
• Deals Landscape
• Mergers, Acquisitions, and Strategic Alliances by Region
• Overview of Recent Deals
• Commercial Assessment
• Key Market Players
• Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the BV market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global BV market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.